Warning: The NCBI web site requires JavaScript to function. more...
Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study.
Llewellyn DJ, Lang IA, Matthews FE, Plassman BL, Rogers MA, Morgenstern LB, Fisher GG, Kabeto MU, Langa KM.
Alzheimers Res Ther. 2010 Jun 24;2(3):19.
Related citations
Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study.
Zhu L, Fratiglioni L, Guo Z, Basun H, Corder EH, Winblad B, Viitanen M.
Stroke. 2000 Jan;31(1):53-60.
Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.
Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R.
JAMA. 1997 Mar 12;277(10):818-21.
Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish Brain Power initiative.
Wang HX, Gustafson DR, Kivipelto M, Pedersen NL, Skoog I, Windblad B, Fratiglioni L.
Neurobiol Aging. 2011 Nov 4. [Epub ahead of print]
Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.
Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW, Taaffe DR, Launer LJ, White LR.
Arch Gen Psychiatry. 2008 Aug;65(8):906-12.
Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C.
Stroke. 2000 Oct;31(10):2431-6.
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality.
Skoog I, Hesse C, Aevarsson O, Landahl S, Wahlström J, Fredman P, Blennow K.
J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):37-43.
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA.
Neurology. 1996 Mar;46(3):673-7.
APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.
Neurology. 2004 Oct 26;63(8):1399-402.
Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.
Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ.
Arch Neurol. 2008 Jan;65(1):89-93.
Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.
Arch Neurol. 2006 Nov;63(11):1586-90.
Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C, Winblad B, Fratiglioni L.
Neurol Res. 2006 Sep;28(6):650-6.
Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study.
Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, Hachinski V, Cedazo-Minguez A, Soininen H, Tuomilehto J, Nissinen A.
J Cell Mol Med. 2008 Dec;12(6B):2762-71. Epub 2008 Feb 8.
APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.
Neurology. 2000 Apr 11;54(7):1492-7.
Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study.
Margaglione M, Seripa D, Gravina C, Grandone E, Vecchione G, Cappucci G, Merla G, Papa S, Postiglione A, Di Minno G, Fazio VM.
Stroke. 1998 Feb;29(2):399-403.
Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study.
Djoussé L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G, Peacock JM, Ellison RC.
Stroke. 2002 May;33(5):1357-61.
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM.
JAMA. 1997 Oct 22-29;278(16):1349-56.
Increased risk of dementia following mild head injury for carriers but not for non-carriers of the APOE epsilon4 allele.
Sundström A, Nilsson LG, Cruts M, Adolfsson R, Van Broeckhoven C, Nyberg L.
Int Psychogeriatr. 2007 Feb;19(1):159-65. Epub 2006 May 10.
The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
Klages J, Fisk JD.
Brain Cogn. 2002 Jul;49(2):201-4.
Association of prior stroke with cognitive function and cognitive impairment: a population-based study.
Knopman DS, Roberts RO, Geda YE, Boeve BF, Pankratz VS, Cha RH, Tangalos EG, Ivnik RJ, Petersen RC.
Arch Neurol. 2009 May;66(5):614-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on